Recent recalls of prescription drugs and other events have led to concerns about how well the drug safety system monitors and addresses the safety of prescription medications after they reach the market. THE FUTURE OF DRUG SAFETY: PROMOTING AND PROTECTING THE HEALTH OF THE PUBLIC, a new report from the Institute of Medicine, assesses the system's strengths and shortcomings and offers a plan for improving the evaluation of medications on an ongoing basis. The report will be released at a one-hour news conference on Tuesday, Sept. 26.
11 a.m. in in the Lecture Room of the National Academies building, 2100 C St., N.W., Washington, D.C. Those who cannot attend may listen to a live audio webcast and submit questions using an e-mail form at http://national-academies.org.
PARTICIPATING FROM THE COMMITTEE THAT WROTE THE REPORT:
-- Sheila Burke, deputy secretary and chief operating officer, Smithsonian Institution, Washington, D.C.
-- Alta Charo, professor of law, School of Law; and professor of bioethics, School of Medicine, University of Wisconsin, Madison
-- Bruce Psaty, professor of medicine, epidemiology, and health services, Cardiovascular Health Research Unit, University of Washington, Seattle
REPORTERS: OBTAIN AN ADVANCE COPY OR REGISTER TO ATTEND by contacting the National Academies' Office of News and Public Information at tel. 202-334-2138 or e-mail email@example.com. Advance copies of the report will be available to reporters only beginning at 8:30 a.m. EDT on Tuesday, Sept. 26. THE REPORT IS EMBARGOED AND NOT FOR PUBLIC RELEASE BEFORE 11 A.M. EDT ON SEPT. 26.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.